8AJL

Structure of the Ancestral Scaffold Antigen-6 of Coronavirus Spike protein


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.77 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

Starting Models: experimental
View more details

wwPDB Validation   3D Report Full Report


This is version 1.3 of the entry. See complete history


Literature

Design, structure and plasma binding of ancestral beta-CoV scaffold antigens.

Hueting, D.Schriever, K.Sun, R.Vlachiotis, S.Zuo, F.Du, L.Persson, H.Hofstrom, C.Ohlin, M.Wallden, K.Buggert, M.Hammarstrom, L.Marcotte, H.Pan-Hammarstrom, Q.Andrell, J.Syren, P.O.

(2023) Nat Commun 14: 6527-6527

  • DOI: https://doi.org/10.1038/s41467-023-42200-x
  • Primary Citation of Related Structures:  
    8AJA, 8AJL

  • PubMed Abstract: 

    We report the application of ancestral sequence reconstruction on coronavirus spike protein, resulting in stable and highly soluble ancestral scaffold antigens (AnSAs). The AnSAs interact with plasma of patients recovered from COVID-19 but do not bind to the human angiotensin-converting enzyme 2 (ACE2) receptor. Cryo-EM analysis of the AnSAs yield high resolution structures (2.6-2.8 Å) indicating a closed pre-fusion conformation in which all three receptor-binding domains (RBDs) are facing downwards. The structures reveal an intricate hydrogen-bonding network mediated by well-resolved loops, both within and across monomers, tethering the N-terminal domain and RBD together. We show that AnSA-5 can induce and boost a broad-spectrum immune response against the wild-type RBD as well as circulating variants of concern in an immune organoid model derived from tonsils. Finally, we highlight how AnSAs are potent scaffolds by replacing the ancestral RBD with the wild-type sequence, which restores ACE2 binding and increases the interaction with convalescent plasma.


  • Organizational Affiliation

    School of Engineering Sciences in Chemistry, Biotechnology and Health, Department of Fibre and Polymer Technology, KTH Royal Institute of Technology, Stockholm, Sweden.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Spike glycoprotein,FibritinA,
B [auth C],
C [auth B]
1,259Severe acute respiratory syndrome coronavirusTequatrovirus T4
This entity is chimeric
Mutation(s): 232 
Gene Names: S2wac
UniProt
Find proteins for P0DTC2 (Severe acute respiratory syndrome coronavirus 2)
Explore P0DTC2 
Go to UniProtKB:  P0DTC2
Find proteins for P10104 (Enterobacteria phage T4)
Explore P10104 
Go to UniProtKB:  P10104
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupsP0DTC2P10104
Glycosylation
Glycosylation Sites: 18Go to GlyGen: P0DTC2-1
Sequence Annotations
Expand
  • Reference Sequence
Oligosaccharides

Help

Entity ID: 2
MoleculeChains Length2D Diagram Glycosylation3D Interactions
2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
D [auth L],
E [auth M],
F [auth N],
G [auth P],
H [auth Q],
D [auth L],
E [auth M],
F [auth N],
G [auth P],
H [auth Q],
I [auth R],
J [auth U],
K [auth V],
L [auth W]
2N-Glycosylation
Glycosylation Resources
GlyTouCan:  G42666HT
GlyCosmos:  G42666HT
GlyGen:  G42666HT
Small Molecules
Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
NAG (Subject of Investigation/LOI)
Query on NAG

Download Ideal Coordinates CCD File 
AA [auth A]
AB [auth B]
BA [auth C]
BB [auth B]
CA [auth C]
AA [auth A],
AB [auth B],
BA [auth C],
BB [auth B],
CA [auth C],
CB [auth B],
DA [auth C],
DB [auth B],
EA [auth C],
EB [auth B],
FA [auth C],
GA [auth C],
HA [auth C],
IA [auth C],
JA [auth C],
KA [auth C],
LA [auth C],
M [auth A],
MA [auth C],
N [auth A],
NA [auth C],
O [auth A],
OA [auth C],
P [auth A],
PA [auth C],
Q [auth A],
QA [auth B],
R [auth A],
RA [auth B],
S [auth A],
SA [auth B],
T [auth A],
TA [auth B],
U [auth A],
UA [auth B],
V [auth A],
VA [auth B],
W [auth A],
WA [auth B],
X [auth A],
XA [auth B],
Y [auth A],
YA [auth B],
Z [auth A],
ZA [auth B]
2-acetamido-2-deoxy-beta-D-glucopyranose
C8 H15 N O6
OVRNDRQMDRJTHS-FMDGEEDCSA-N
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.77 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX1.3
RECONSTRUCTIONISOLDE1.1

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other government2019-700
Other governmentSNIC 2021/5-70
The Swedish Foundation for Strategic ResearchSwedenFFF20-0027
European Union (EU)European UnionATAC, 101003650
Knut and Alice Wallenberg FoundationSwedenSciLifeLab/KAW national COVID-19 research program project grant 2020 (KAW 2020.0182)

Revision History  (Full details and data files)

  • Version 1.0: 2023-08-16
    Type: Initial release
  • Version 1.1: 2023-08-30
    Changes: Database references
  • Version 1.2: 2023-11-01
    Changes: Database references, Refinement description
  • Version 1.3: 2024-10-09
    Changes: Data collection, Structure summary